203 related articles for article (PubMed ID: 2953866)
1. Acetylcholinesterase and butyrylcholinesterase activity in the cerebrospinal fluid of patients with neurodegenerative diseases involving cholinergic systems.
Ruberg M; Villageois A; Bonnet AM; Pillon B; Rieger F; Agid Y
J Neurol Neurosurg Psychiatry; 1987 May; 50(5):538-43. PubMed ID: 2953866
[TBL] [Abstract][Full Text] [Related]
2. Acetyl- and butyrylcholinesterase activity in the cerebrospinal fluid of patients with Parkinson's disease.
Sirviö J; Soininen HS; Kutvonen R; Hyttinen JM; Helkala EL; Riekkinen PJ
J Neurol Sci; 1987 Nov; 81(2-3):273-9. PubMed ID: 3694232
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid cholinesterases in aging and in dementia of the Alzheimer type.
Atack JR; May C; Kaye JA; Kay AD; Rapoport SI
Ann Neurol; 1988 Feb; 23(2):161-7. PubMed ID: 3377438
[TBL] [Abstract][Full Text] [Related]
4. Acetylcholinesterase and butyrylcholinesterase in frontal cortex and cerebrospinal fluid of demented and non-demented patients with Parkinson's disease.
Ruberg M; Rieger F; Villageois A; Bonnet AM; Agid Y
Brain Res; 1986 Jan; 362(1):83-91. PubMed ID: 3942870
[TBL] [Abstract][Full Text] [Related]
5. Activities and kinetic properties of lumbar cerebrospinal fluid cholinesterases in relation to clinical diagnosis, severity, and progression of Alzheimer's disease.
Huff FJ; Reiter CT; Protetch J
Can J Neurol Sci; 1989 Nov; 16(4):406-10. PubMed ID: 2804802
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid acetylcholinesterase in progressive supranuclear palsy: reduced activity relative to normal subjects and lack of inhibition by oral physostigmine.
Atack JR; Litvan I; Thal LJ; May C; Rapoport SI; Chase TN
J Neurol Neurosurg Psychiatry; 1991 Sep; 54(9):832-5. PubMed ID: 1955905
[TBL] [Abstract][Full Text] [Related]
7. Cholinesterase activities in cerebrospinal fluid of patients with senile dementia of Alzheimer type.
Appleyard ME; Smith AD; Berman P; Wilcock GK; Esiri MM; Neary D; Bowen DM
Brain; 1987 Oct; 110 ( Pt 5)():1309-22. PubMed ID: 3676702
[TBL] [Abstract][Full Text] [Related]
8. Cholinesterases in cerebrospinal fluid. Correlations with clinical measures in Alzheimer's disease.
Huff FJ; Maire JC; Growdon JH; Corkin S; Wurtman RJ
J Neurol Sci; 1986 Feb; 72(2-3):121-9. PubMed ID: 3711929
[TBL] [Abstract][Full Text] [Related]
9. Acetylcholinesterase and butyrylcholinesterase activities in cerebrospinal fluid from different levels of the neuraxis of patients with dementia of the Alzheimer type.
Appleyard ME; McDonald B
J Neurol Neurosurg Psychiatry; 1992 Nov; 55(11):1074-8. PubMed ID: 1469405
[TBL] [Abstract][Full Text] [Related]
10. Cholinesterases in the cerebrospinal fluid, plasma, and erythrocytes of patients with Alzheimer's disease.
Sirviö J; Kutvonen R; Soininen H; Hartikainen P; Riekkinen PJ
J Neural Transm; 1989; 75(2):119-27. PubMed ID: 2918304
[TBL] [Abstract][Full Text] [Related]
11. Changes in acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease resemble embryonic development--a study of molecular forms.
Arendt T; Brückner MK; Lange M; Bigl V
Neurochem Int; 1992 Oct; 21(3):381-96. PubMed ID: 1303164
[TBL] [Abstract][Full Text] [Related]
12. [CSF acetylcholinesterase activity in central neurological diseases involving cholinergic systems].
Konagaya M; Konagaya Y; Iida M
Rinsho Shinkeigaku; 1992 Mar; 32(3):266-71. PubMed ID: 1628449
[TBL] [Abstract][Full Text] [Related]
13. The significance of the activity of CSF cholinesterases in dementias.
Shen ZX
Med Hypotheses; 1996 Nov; 47(5):363-76. PubMed ID: 8951800
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid cholinesterases--markers for loss of cholinergic basal forebrain neurons?
Rossner S; Bakinde N; Zeitschel U; Schliebs R; Bigl V
Int J Dev Neurosci; 1998; 16(7-8):669-73. PubMed ID: 10198815
[TBL] [Abstract][Full Text] [Related]
15. Cholinesterases in cerebrospinal fluid. A longitudinal study in Alzheimer disease.
Elble R; Giacobini E; Scarsella GF
Arch Neurol; 1987 Apr; 44(4):403-7. PubMed ID: 3827696
[TBL] [Abstract][Full Text] [Related]
16. Molecular forms of cholinesterases in CSF of Alzheimer's disease/senile dementia of Alzheimer type patients and matched neurological controls.
Bisso GM; Masullo C; Michalek H; Silveri MC; Pocchiari M
Life Sci; 1986 Feb; 38(6):561-7. PubMed ID: 3945178
[TBL] [Abstract][Full Text] [Related]
17. Molecular forms of acetylcholinesterase and butyrylcholinesterase in human plasma and cerebrospinal fluid.
Atack JR; Perry EK; Bonham JR; Perry RH
J Neurochem; 1987 Jun; 48(6):1845-50. PubMed ID: 3572402
[TBL] [Abstract][Full Text] [Related]
18. Cholinesterase activity in plasma, erythrocytes, and cerebrospinal fluid of patients with dementia of the Alzheimer type.
Marquis JK; Volicer L; Mark KA; Direnfeld LK; Freedman M
Biol Psychiatry; 1985 Jun; 20(6):605-10. PubMed ID: 3995108
[TBL] [Abstract][Full Text] [Related]
19. Serum and CSF cholinesterase activity in various kinds of dementia.
Szilágyi AK; Németh A; Martini E; Lendvai B; Venter V
Eur Arch Psychiatry Neurol Sci; 1987; 236(5):309-11. PubMed ID: 3653153
[TBL] [Abstract][Full Text] [Related]
20. Changes in CSF acetyl- and butyrylcholinesterase activity after long-term treatment with AChE inhibitors in Alzheimer's disease.
Parnetti L; Chiasserini D; Andreasson U; Ohlson M; Hüls C; Zetterberg H; Minthon L; Wallin AK; Andreasen N; Talesa VN; Blennow K
Acta Neurol Scand; 2011 Aug; 124(2):122-9. PubMed ID: 20880294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
